Acta Neuropathologica

, Volume 60, Issue 1–2, pp 75–80 | Cite as

In vitro propagation of the scrapie agent

I. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted scrapie strain c-506
  • P. Markovits
  • C. Dautheville
  • D. Dormont
  • L. Dianoux
  • R. Latarjet
Original Works

Summary

Seven cell lines including glia cells from mouse brains and mouse neuroblastoma cells were infected with the mouse-adapted scrapie strain c-506. During the early in vitro passages, a stimulation of growth was already observed but cellular morphology and differentiation did not alter. Later on, after 12–16 passages, six of the seven infected lines displayed cell proliferation and morphological alterations, suggesting an in vitro morphological transformation. At this stage, differentiation was no longer observed in the scrapie-infected neuroblastoma cells and all the scrapie-infected cells formed two to four times more colonies in liquid medium than the controls, and developed large tridimensional colonies in agar. The part played by the scrapie agent in these changes is discussed.

Key words

Scrapie Slow virus diseases Transformation Neural cells Differentiation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alper J, Haig DA, Clarke MC (1978) The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J Gen Virol 41:503–516Google Scholar
  2. Amano J, Richelson E Nirenberg M (1972) Neurotransmitter synthesis by neuroblastoma clones. Proc Natl Acad Sci USA 60:258–263Google Scholar
  3. Borras MT, Kingsbury OT, Gajdusek DC, Gibbs CJ (1982) Inability to transmit scrapie by transfection of mouse embryo cells in vitro. J Gen Virol 58:263–271Google Scholar
  4. Cho HJ (1980) Requirement of a protein component for scrapie infectivity. Intervirology 14:213–216Google Scholar
  5. Clarke MC (1979) Infection of cell culture with scrapie agent. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic Press, New York London, pp 225–233Google Scholar
  6. Dormont D, Delpech B, Delpech A, Courel MN, Viret J, Markovits P, Court L (1981) Hyperproduction de proteine glio-fibrillaire acide (GFA) au cours de l'évolution de la tremblante experimentale de la souris. CR Acad Sci III 293:53–57Google Scholar
  7. Fraser H (1979) Neuropathology of scrapie: The precision of the lesions and their diversity. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous syste, vol I. Academic Press, New York London, pp 387–406Google Scholar
  8. Gibbs CJ, Gajdusek DC (1974) Cell-virus interactions in slow infections of the nervous system. In: Schmitt FO, Worden FG (eds) The neurosciences, third study program. MIT Press, Cambridge, pp 1025–1041Google Scholar
  9. Haig DA, Pattison IH (1967) In vitro growth of pieces of brain from scrapie-infected mice. J Pathol Bacteriol 93:724–727Google Scholar
  10. Hooks J, Gibbs CJ, Chopra H, Lewis M, Gajdusek DC (1972) Science 176:1420–1422Google Scholar
  11. Kingsbury DT, Smeltzer DA, Gibbs CJ, Gajdusek DC (1981) Evidence for normal cell-mediated immunity in scrapie-infected mice. Infect Immun 32:1176–1180Google Scholar
  12. Latarjet R, Muel B, Haig DA, Alper J (1970) Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature 227:1341–1343Google Scholar
  13. Latarjet R (1979) Inactivation of the agents of scrapie. Creutzfeldt-Jakob disease, and kuru by radiations. In: Prosiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 2. Academic Press, New York London, pp 387–407Google Scholar
  14. Mac Pherson I, Montagnier L (1964) Agar suspension cultures for the selective assay of cells transformed by polyoma virus. Virology 23:291–294Google Scholar
  15. Markovits P, Maunoury R, Tripier MF, Coulomb B, Levy S, Papadopoulo D, Vedreune C, Benda P (1979) Normal and benzopyrene transformed cells. I. Acta Neuropathol (Berl) 47:197–203Google Scholar
  16. Markovits P, Dormont D, Maunoury R, Delamarche C, Delpech A, Dianoux L, Latarjet R (1982) Modifications in vitro de la morphologie et de la croissance de cellules infectées par l'agent scrapie. CR Acad Sci Paris III 294:305–312Google Scholar
  17. Marsh RF (1976) The subacute spongiform encephalopathies. In: Kimberlin RH (ed) Slow virus diseases of animals and man. North Holland Elsevier, Amsterdam Oxford New York, pp 359–380Google Scholar
  18. Millson GC, Hunter GD, Kimberlin RH (1976) The physicochemical nature of the scrapie agent. In: Kimberlin RH (ed) Slow virus disease of animals and man. North Holland Elsevier, Amsterdam Oxford New York, pp 243–266Google Scholar
  19. Porter DD, Porter HG, Cox NA (1973) Failure to demonstrate a humoral immune response to scrapie infection in mice. J Immunol 3:1407–1410Google Scholar
  20. Prusiner SB, Groth DF, Mc Kinley MP, Cochran SP, Bauman KA, Kasper KC (1981) Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc Natl Acad Sci USA 78:4606–4610Google Scholar
  21. Yamagihara RT, Asher DM, Gibbs CJ, Gajdusek DC (1980) Attempts to establish cell cultures infected with the viruses of subacute spongiform encephalopathies. Proc Soc Exp Biol Med 165:298–305Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • P. Markovits
    • 1
  • C. Dautheville
    • 1
  • D. Dormont
    • 2
  • L. Dianoux
    • 3
  • R. Latarjet
    • 1
  1. 1.Institut CurieParis, 231France
  2. 2.Centre de Recherche du Service de Santé des ArméesClamartFrance
  3. 3.INSERM, U 107Hôpital St. LouisParisFrance

Personalised recommendations